非小细胞肺癌病人常见免疫治疗不良反应的影响因素分析

徐晓婉; 唐淑慧; 张锚; 管诗佳; 徐晓婉; 唐淑慧; 张锚; 管诗佳

doi:10.13898/j.cnki.issn.1000-2200.2022.08.025

[1]

ROSELL R, KARACHALIOU N. Large-scale screening for somatic mutations in lung cancer[J]. Lancet, 2016, 387(10026): 1354. doi: 10.1016/S0140-6736(15)01125-3

[2]

朱雨荷, 李玉云. 抗PD-1/PD-Ls抗体在肿瘤治疗中的应用研究进展[J]. 蚌埠医学院学报, 2019, 44(5): 698.

[3]

王琦. 中医体质学: 2008[M]. 北京: 人民卫生出版社, 2009.

[4]

NAIDOO J, PAGE DB, LI BT, et al. Toxicities of the anti-PD-1 and anti-PD-L1 immune checkpoint antibodies[J]. Ann Oncol, 2015, 26(12): 2375. doi: 10.1093/annonc/mdv383

[5]

杨晓娜, 姚菊峰, 姬方婧. 中医体质与化疗后毒副反应的关系[J]. 当代护士(学术版), 2014(4): 169.

[6]

WANG Y, ABU-SBEIH H, MAO E, et al. endoscopic and histologic features of immune checkpoint inhibitor-related colitis[J]. Infamm Bowel Dis, 2018, 24(8): 1695. doi: 10.1093/ibd/izy104

[7]

U.S. Department of Health and Human Services. Common terminology criteria for adverse events (CTCAE) version 5.0[EB/OL]. (2017-11-27)[2020-08-02]. https://ctep.cancer.gov/protocolDevelopment/electronic_applications/docs/CTCAE_v5_Quick_Reference_5x7.pdf.

[8]

CTCAE v5.0 incorporates certain elements of the MedDRA terminology. For further details on MedDRA refer to the MedDRA MSSO Web site(https://www.meddra.org/).

[9]

高小月, 侯黎莉, 顾芬, 商丽艳, 黄莹. 肺癌化疗病人中医体质影响因素分析[J]. 循证护理, 2019, 5(2): 142.

[10]

SZNOL M, POSTOW MA, DAVIES MJ, et al. Endocrine-related adverse events associated with immune checkpoint blockade and expert insights on their management[J]. Cancer Treat Rev, 2017, 58: 70. doi: 10.1016/j.ctrv.2017.06.002

[11]

BARROSO-SOUSA R, BARRY WT, GARRIDO-CASTRO AC, et al. Incidence of endocrine dysfunction following the use of di erent immune checkpoint inhibitor regimens: a systematic review and Meta-analysis[J]. JAMA Oncol, 2018, 4(2): 173. doi: 10.1001/jamaoncol.2017.3064

[12]

NAIDOO J, WANG X, WOO KM, et al. Pneumonitis in patients treated with anti-programmed death-1/programmed death ligand 1 therapy[J]. J Clin Oncol, 2017, 35(7): 709. doi: 10.1200/JCO.2016.68.2005

[13]

高小月, 顾芬, 侯黎莉. 初诊非小细胞肺癌患者化疗所致恶心呕吐的动态变化及护理对策[J]. 中华现代护理杂志, 2019, 25(1): 68.

[14]

唐淑慧, 侯黎莉, 王汇. 非小细胞肺癌患者免疫治疗致皮肤毒性的调查研究[J]. 护理学杂志, 2020, 35(16): 35.

[15]

胡琪, 于雪峰, 黎雨, 等. 抗PD-1/PD-L1免疫检查点抑制剂的皮肤免疫相关不良反应的研究进展[J]. 现代肿瘤医学, 2020, 28(4): 652. doi: 10.3969/j.issn.1672-4992.2020.04.030

[16]

TANDON P, BOURASSA-BLANCHETTE S, BISHAY K, et al. The risk of diarrhea and colitis in patients with advanced melanoma undergoing immune checkpoint inhibitor therapy: a systematic review and meta-analysis[J]. J Immunother, 2018, 41(3): 101. doi: 10.1097/CJI.0000000000000213